Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Accent Therapeutics
AddedFeb 15, 2024
UpdatedJun 18, 2026
Accent Therapeutics

Accent Therapeutics

Accent Therapeutics, a NY-based biopharmaceutical company, specializes in developing inhibitory molecule drugs.

HQ
Lexington, MA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Accent Therapeutics is a biopharmaceutical company based in New York, specializing in the development of inhibitory molecule drugs within the field of epitranscriptomics. The company's mission is to advance the understanding and treatment of diseases by targeting RNA-modifying proteins. Accent Therapeutics focuses on creating innovative therapies that can address unmet medical needs, particularly in oncology.

The company has made significant strides in its research and development efforts, presenting data on its two lead programs at the American Association for Cancer Research (AACR) Annual Meeting. These programs target DHX9 and KIF18A, which have been identified as compelling therapeutic targets. Accent Therapeutics' work has garnered attention within the scientific community, contributing to the broader understanding of cancer treatment and enhancing the potential for new, effective therapies.

Accent Therapeutics - Similar Companies

Accentia Biopharmaceuticals logo

Accentia Biopharmaceuticals

Acylin Therapeutics logo

Acylin Therapeutics

Adcentrx Therapeutics logo

Adcentrx Therapeutics

adcentrx.com

Akttyva Therapeutics logo

Akttyva Therapeutics

akttyva.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Ajax Therapeutics logo

Ajax Therapeutics

Ascent Therapeutics logo

Ascent Therapeutics

Accera logo

Accera

Akebia Therapeutics logo

Akebia Therapeutics

akebia.com

858 Therapeutics logo

858 Therapeutics

8five8tx.com

Nextrna Therapeutics logo

Nextrna Therapeutics

Remix Therapeutics logo

Remix Therapeutics

Initial Therapeutics logo

Initial Therapeutics

initialtx.com

Accuronix Therapeutics logo

Accuronix Therapeutics

accuronix.com

Ascenta Therapeutics logo

Ascenta Therapeutics

Accent Therapeutics - Quick Facts

Who are Accent Therapeutics' competitors?

Companies similar to Accent Therapeutics include Accentia Biopharmaceuticals, Acylin Therapeutics, Adcentrx Therapeutics and Akttyva Therapeutics.

When was Accent Therapeutics founded?

Accent Therapeutics was founded in 2017.

Where is Accent Therapeutics' headquarters located?

Accent Therapeutics' headquarters is located in Lexington, MA, US.

When was Accent Therapeutics' last funding round?

Accent Therapeutics' most recent funding round was for $75M (USD) in January 2024.

How much has Accent Therapeutics raised to-date?

As of Jan 23, 2024, Accent Therapeutics has raised a total of $178M (USD).

How many employees does Accent Therapeutics have?

Accent Therapeutics has 69 employees as of Feb 4, 2024.

Accent Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • SaaS
Customer
  • Enterprise
Main Product
  • Drug Development
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified